{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-291534","form_type":"8-K","ticker":"FNCHQ","cik":"0001733257","company_name":"Finch Therapeutics Group, Inc.","filed_at":"2021-10-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.877983+00:00","generated_at":"2026-06-28T23:02:33.570524+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Finch Therapeutics appoints Samuel Allen Hamood to Board of Directors","bullets":["Hamood elected as Class I director effective Oct 1, 2021; also chairs new Finance Committee.","Annual cash retainers: $35,000 for Board, $5,000 for Finance Committee, $10,000 as chair.","Initial equity grant: option to buy 25,543 shares at $12.94, $200,000 fair value, 3-year vest.","Hamood serves as President and CAFO of Culligan International; 30+ years of finance experience.","Board determined Hamood qualifies as independent under SEC and Nasdaq standards."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-291534","json":"https://secwatch.observer/filing/0001193125-21-291534.json","markdown":"https://secwatch.observer/filing/0001193125-21-291534.md","text":"https://secwatch.observer/filing/0001193125-21-291534.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1733257/000119312521291534/0001193125-21-291534-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1733257/000119312521291534/d222985d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T23:02:33.570524+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"405bf694ae","claim":"Samuel Allen Hamood was elected as Director at Finch Therapeutics Group, Inc..","evidence_excerpt":"elected Samuel Allen Hamood to the Board, effective immediately, to serve as a Class I director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1733257/000119312521291534/0001193125-21-291534-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}